{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:39:13Z","timestamp":1794487153823,"version":"4.9.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Infrastructure for preclinical and early-phase clinical development of drugs, therapeutics and biomedical devices (EATRIS-GR)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1038\/s41397-022-00291-7","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T16:02:53Z","timestamp":1665676973000},"page":"8-13","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Protein network and pathway analysis in a pharmacogenetic study of cyclosporine treatment response in Greek patients with psoriasis"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5967-9367","authenticated-orcid":false,"given":"Charalabos","family":"Antonatos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Patsatsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efterpi","family":"Zafiriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleana F.","family":"Stavrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0764-2933","authenticated-orcid":false,"given":"Andreas","family":"Liaropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Kyriakoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Evangelou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danai","family":"Digka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeliki","family":"Roussaki-Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Sotiriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6569-1928","authenticated-orcid":false,"given":"Katerina","family":"Grafanaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2556-537X","authenticated-orcid":false,"given":"Nicholas \u039a.","family":"Moschonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3167-7642","authenticated-orcid":false,"given":"Yiannis","family":"Vasilopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,13]]},"reference":[{"key":"291_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","volume":"133","author":"R Parisi","year":"2013","unstructured":"Parisi R, Symmons DPM, Griffiths CEM, Ashcroft DM. Global epidemiology of psoriasis: A systematic review of incidence and prevalence. J Investigative Dermatol. 2013;133:377\u201385.","journal-title":"J Investigative Dermatol"},{"key":"291_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1684\/ejd.2010.0869","volume":"20","author":"D Rigopoulos","year":"2010","unstructured":"Rigopoulos D, Gregoriou S, Katrinaki A, Korfitis C, Larios G, Stamou C, et al. Characteristics of psoriasis in Greece: An epidemiological study of a population in a sunny Mediterranean climate. Eur J Dermatol. 2010;20:189\u201395.","journal-title":"Eur J Dermatol"},{"key":"291_CR3","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.3389\/fimmu.2018.02746","volume":"9","author":"A Mylonas","year":"2018","unstructured":"Mylonas A, Conrad C. Psoriasis: Classical vs. Paradoxical. The Yin-Yang of TNF and type I Interferon. Front Immunol. 2018;9:2746.","journal-title":"Front Immunol."},{"key":"291_CR4","first-page":"97","volume":"93","author":"F Gr\u00e4n","year":"2020","unstructured":"Gr\u00e4n F, Kerstan A, Serfling E, Goebeler M, Muhammad K. Current developments in the immunology of psoriasis. Yale J Biol Med. 2020;93:97\u2013110.","journal-title":"Yale J Biol Med"},{"key":"291_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/805705","volume":"2013","author":"MD Colombo","year":"2013","unstructured":"Colombo MD, Cassano N, Bellia G, Vena GA. Cyclosporine regimens in plaque psoriasis: An overview with special emphasis on dose, duration, and old and new treatment approaches. Sci World J. 2013;2013:1\u201311.","journal-title":"Sci World J"},{"key":"291_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","volume":"47","author":"S Matsuda","year":"2000","unstructured":"Matsuda S, Koyasu S. Mechanisms of action of cyclosporine. Immunopharmacology. 2000;47:119\u201325.","journal-title":"Immunopharmacology"},{"key":"291_CR7","unstructured":"Singh, K & Arg\u00e1ez, C. Cyclosporine for Moderate to Severe Plaque Psoriasis in Adults: A Review of Clinical Effectiveness and Safety. (Canadian Agency for Drugs and Technologies in Health, 2018)."},{"key":"291_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40257-017-0322-9","volume":"19","author":"MC Ovejero-Benito","year":"2018","unstructured":"Ovejero-Benito MC, Mu\u00f1oz-Aceituno E, Reolid A, Saiz-Rodr\u00edguez M, Abad-Santos F, Daud\u00e9n E. Pharmacogenetics and pharmacogenomics in moderate-to-severe psoriasis. Am J Clin Dermatol. 2018;19:209\u201322.","journal-title":"Am J Clin Dermatol"},{"key":"291_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/bioinformatics\/btaa1070","volume":"37","author":"GN Dimitrakopoulos","year":"2021","unstructured":"Dimitrakopoulos GN, Klapa MI, Moschonas NK. PICKLE 3.0: Enriching the human meta-database with the mouse protein interactome extended via mouse\u2013human orthology. Bioinformatics. 2021;37:145\u20136.","journal-title":"Bioinformatics"},{"key":"291_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/biom12010140","volume":"12","author":"GN Dimitrakopoulos","year":"2022","unstructured":"Dimitrakopoulos GN, Klapa MI, Moschonas NK. How far are we from the completion of the human protein interactome reconstruction? Biomolecules 2022;12:140.","journal-title":"Biomolecules"},{"key":"291_CR11","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u2013504.","journal-title":"Genome Res"},{"key":"291_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/tpj.2014.23","volume":"14","author":"Y Vasilopoulos","year":"2014","unstructured":"Vasilopoulos Y, Sarri C, Zafiriou E, Patsatsi A, Stamatis C, Ntoumou E, et al. A pharmacogenetic study of ABCB1 polymorphisms and cyclosporine treatment response in patients with psoriasis in the Greek population. Pharmacogenomics J. 2014;14:523\u20135.","journal-title":"Pharmacogenomics J"},{"key":"291_CR13","doi-asserted-by":"crossref","unstructured":"Gabriel S, Ziaugra L & Tabbaa D. SNP Genotyping using the sequenom MassARRAY iPLEX platform. Curr Protocols Human Genet. 2009;60 (Chapter 2: Unit 2.12).","DOI":"10.1002\/0471142905.hg0212s60"},{"key":"291_CR14","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ajhg.2007.11.004","volume":"82","author":"DY Lin","year":"2008","unstructured":"Lin DY, Hu Y, Huang BE. Simple and efficient analysis of disease association with missing genotype data. Am J Hum Genet. 2008;82:444\u201352.","journal-title":"Am J Hum Genet"},{"key":"291_CR15","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun S-C. NF-\u03baB signaling in inflammation. Sig Transduct Target Ther. 2017;2:17023.","journal-title":"Sig Transduct Target Ther"},{"key":"291_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.proghi.2004.04.001","volume":"39","author":"R Rezzani","year":"2004","unstructured":"Rezzani R. Cyclosporine A and adverse effects on organs: histochemical studies. Prog Histochemistry Cytochemistry. 2004;39:85\u2013128.","journal-title":"Prog Histochemistry Cytochemistry"},{"key":"291_CR17","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/cr.2016.14","volume":"26","author":"S-J Li","year":"2016","unstructured":"Li S-J, Wang J, Ma L, Lu C, Wang J, Wu J-W, et al. Cooperative autoinhibition and multi-level activation mechanisms of calcineurin. Cell Res. 2016;26:336\u201349.","journal-title":"Cell Res"},{"key":"291_CR18","doi-asserted-by":"publisher","first-page":"e1001101","DOI":"10.1371\/journal.pgen.1001101","volume":"6","author":"C Cruchaga","year":"2010","unstructured":"Cruchaga C, Kauwe JSK, Mayo K, Spiegel N, Bertelsen S, Nowotny P, et al. SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer\u2019s Disease. PLoS Genet. 2010;6:e1001101.","journal-title":"PLoS Genet"},{"key":"291_CR19","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.neurobiolaging.2012.05.003","volume":"34","author":"CM Karch","year":"2013","unstructured":"Karch CM, Jeng AT, Goate AM. Calcium phosphatase calcineurin influences tau metabolism. Neurobiol Aging. 2013;34:374\u201386.","journal-title":"Neurobiol Aging"},{"key":"291_CR20","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3389\/fnmol.2018.00396","volume":"11","author":"HH Jensen","year":"2018","unstructured":"Jensen HH, Brohus M, Nyegaard M, Overgaard MT. Human Calmodulin Mutations. Front Mol Neurosci 2018;11:396.","journal-title":"Front Mol Neurosci"},{"key":"291_CR21","doi-asserted-by":"crossref","unstructured":"Toutenhoofd SL, Foletti D, Wicki R, Rhyner A, Garcia F, ToIon R, et al. Of the human CALM2 calmodulin gene and comparison of the transcriptional activity of CALIVlly CALM2 and CALM3. Cell Calcium 1998;16:323\u201338.","DOI":"10.1016\/S0143-4160(98)90028-8"},{"key":"291_CR22","doi-asserted-by":"publisher","first-page":"e12235","DOI":"10.1097\/MD.0000000000012235","volume":"97","author":"J Shi","year":"2018","unstructured":"Shi J, Gao S, Lv Z, Sheng W, Kang H. The association between rs12885713 polymorphism in CALM1 and risk of osteoarthritis: A meta-analysis of case\u2013control studies. Medicine. 2018;97:e12235.","journal-title":"Medicine"},{"key":"291_CR23","doi-asserted-by":"publisher","first-page":"e78833","DOI":"10.1371\/journal.pone.0078833","volume":"8","author":"LO Bryzgalov","year":"2013","unstructured":"Bryzgalov LO, Antontseva EV, Matveeva MY, Shilov AG, Kashina EV, Mordvinov VA, et al. Detection of Regulatory SNPs in Human Genome Using ChIP-seq ENCODE Data. PLoS ONE. 2013;8:e78833.","journal-title":"PLoS ONE"},{"key":"291_CR24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/ni1568","volume":"9","author":"F Rebeaud","year":"2008","unstructured":"Rebeaud F, Hailfinger S, Posevitz-Fejfar A, Tapernoux M, Moser R, Rueda D, et al. The proteolytic activity of the paracaspase MALT1 is key in T cell activation. Nat Immunol. 2008;9:272\u201381.","journal-title":"Nat Immunol"},{"key":"291_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.gene.2013.05.015","volume":"527","author":"A Turki","year":"2013","unstructured":"Turki A, Mahjoub T, Mtiraoui N, Abdelhedi M, Frih A, Almawi WY. Association of POL1, MALT1, MC4R, PHLPP and DSEL single nucleotide polymorphisms in chromosome 18q region with type 2 diabetes in Tunisians. Gene. 2013;527:243\u20137.","journal-title":"Gene"},{"key":"291_CR26","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00439-009-0732-8","volume":"126","author":"CW McDonough","year":"2009","unstructured":"McDonough CW, Bostrom MA, Lu L, Hicks PJ, Langefeld CD, Divers J, et al. Genetic analysis of diabetic nephropathy on chromosome 18 in African Americans: linkage analysis and dense SNP mapping. Hum Genet. 2009;126:805\u201317.","journal-title":"Hum Genet"},{"key":"291_CR27","doi-asserted-by":"publisher","first-page":"e0175242","DOI":"10.1371\/journal.pone.0175242","volume":"12","author":"JL Gooch","year":"2017","unstructured":"Gooch JL, King C, Francis CE, Garcia PS, Bai Y. Cyclosporine A alters expression of renal microRNAs: New insights into calcineurin inhibitor nephrotoxicity. PLoS ONE. 2017;12:e0175242.","journal-title":"PLoS ONE"},{"key":"291_CR28","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/nep.12851","volume":"22","author":"J Qiu","year":"2017","unstructured":"Qiu J, Chen Y, Huang G, Zhang Z, Chen L, Na N. Transforming growth factor-\u03b2 activated long non-coding RNA ATB plays an important role in acute rejection of renal allografts and may impacts the postoperative pharmaceutical immunosuppression therapy: lncRNA-ATB in renal allografts. Nephrology. 2017;22:796\u2013803.","journal-title":"Nephrology"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41397-022-00291-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41397-022-00291-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41397-022-00291-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T22:04:13Z","timestamp":1676325853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41397-022-00291-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,13]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["291"],"URL":"https:\/\/doi.org\/10.1038\/s41397-022-00291-7","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,13]]},"assertion":[{"value":"22 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}